Ehsan Rezaie
Overview
Explore the profile of Ehsan Rezaie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rezaie E, Amani J, Bidmeshki Pour A, Mahmoodzadeh Hosseini H
Eur J Pharmacol
. 2020 Jan;
870:172912.
PMID: 31926992
Immunotoxin therapy is one of the immunotherapy strategies providing a new, effective and high potency treatment against various cancers. Breast cancer is the most common cancer among women in many...
12.
Khafaei M, Rezaie E, Mohammadi A, Shahnazi Gerdehsang P, Ghavidel S, Kadkhoda S, et al.
J Cell Physiol
. 2019 Jan;
234(9):14651-14665.
PMID: 30693512
Malignant neoplasms are regarded as the main cause of death around the world; hence, many research studies were conducted to further perceive molecular mechanisms, treatment, and cancer prognosis. Cancer is...
13.
Rezaie E, Nekoie H, Miri A, Oulad G, Ahmadi A, Saadati M, et al.
Microb Pathog
. 2018 Dec;
127:225-232.
PMID: 30528250
Along with robust immunogenicity, an ideal vaccine candidate should be able to produce a long lasting protection. In this regard, the frequency of memory B-cells is possibly an important factor...
14.
Rezaie E, Mohammadi M, Sakhteman A, Bemani P, Ahrari S
J Mol Model
. 2018 Oct;
24(11):313.
PMID: 30324504
Proteins are often monitored by combining a fluorescent polypeptide tag with the target protein. However, due to the high molecular weight and immunogenicity of such tags, they are not suitable...
15.
Keshtvarz M, Salimian J, Yaseri M, Bathaie S, Rezaie E, Aliramezani A, et al.
Immunotherapy
. 2017 Mar;
9(5):387-400.
PMID: 28357912
Aim: AFn14R can serve as an ideal target for cancer immunotherapy. Here, a combined bioinformatic and experimental approach was applied to characterize an immunotoxin consisting of single-chain variable fragment antibody...